Translational Development Acquisition Corp. Cash And Cash Equivalents At Carrying Value

Quick Answer

Translational Development Acquisition Corp. reported Cash And Cash Equivalents At Carrying Value of $29.8 thousand for the year ending 2025.

  • Translational Development Acquisition Corp. showed a decrease of -93.2% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Translational Development Acquisition Corp.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
  • XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 3 years of available data (2023 to 2025), Translational Development Acquisition Corp.'s Cash And Cash Equivalents At Carrying Value has grown by 1,373.9%.
  • Historical annual values: Fiscal year 2025: $29.8 thousand | Fiscal year 2024: $438.2 thousand | Fiscal year 2023: $2.0 thousand.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: